The Europe transplant market is projected to grow at a CAGR of 5.26% to reach a market size of US$ 26.480 billion by 2024, from US$ 19.464 billion in 2018. Transplants are also known as grafts or organ transplants where a section of a tissue or a complete organ from its original site is transferred to the area of interest in an individual (same or separate). Thus, the transplanted organ or graft continue to receive nourishment from the new and healthy environment. Prevalence of chronic diseases is one of the major factors driving the growth of the Europe transplant market in the forecast period. Furthermore, growing health awareness along with government initiatives regarding organ donation is driving the market growth. However, the shortage of organ donors and incidences of transplant rejection may impede the growth of the Europe transplant market during the forecast period. Additionally, technological advancements will drive market growth in the forecast period and in the upcoming years.
The “Europe Transplant Market – Forecasts from 2019 to 2024” is an exhaustive study which aims to present the key market trends through various chapters focusing on different aspects of the market. The study provides a detailed market overview through the market dynamics sections which detail key market, drivers, restraints, and opportunities in the current market. The report analyzes key opportunity regional markets, and the current technology penetration through lifecycle analysis. The report also analyzes the market through comprehensive market segmentation by type, procedure, product, and country.
The Europe Transplant market on segmented based on type, procedure, product, and country. Based on type the market has been segmented into tissue transplant and organ transplant. Organ transplant is further segmented into living donors and deceased donors. By procedure, the market has been segmented into autotransplantation, allotransplantation, and xenotransplantation. By product, the market has been classified into immunosuppressive drugs, preservation solutions, and organ transport systems.
Country-wise analysis has been provided with detailed analysis and forecast for the period 2018 to 2024, taking 2018 as the base year. The regional market has been broken down into Germany, France, United Kingdom, Spain, and Others. The report also analyzes 4 major countries across the European region with thorough analysis and forecast along with prevailing market trends and opportunities which each of these countries present for the manufacturers.
Major players in the Europe transplant market have been covered along with their relative competitive position and strategies. The report also mentions recent deals and investments of different market players over the last year. The company profiles section details the business overview, financial performance for the past three years, key products and services being offered along with the recent developments of these important players in the Europe transplant market.
The Europe Transplant market has been analyzed through following segments:
Organ Transport Systems
Key insights offered
What will be the Europe transplant market size from 2018 to 2024?
How are the major drivers and restraints affecting the Europe transplant market growth and the opportunities which exist for key vendors?
Which segment and region will drive or lead the market growth and why?
A comprehensive analysis of competitive landscape and key market participants’ behaviour
Key strategies being adopted by vendors, with in-depth analysis along with their impact on competition and market growth.
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.6. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter’s Five Force Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness
5. EUROPE TRANSPLANT MARKET BY TYPE
5.1. Tissue Transplant
5.2. Organ Transplant
5.2.1. Living Donors
5.2.2. Deceased Donors
6. EUROPE TRANSPLANT MARKET BY PROCEDURE
7. EUROPE TRANSPLANT MARKET BY PRODUCT
7.1. Immunosuppresive drugs
7.2. Preservation Solutions
7.3. Organ Transport Systems
8. EUROPE TRANSPLANT MARKET BY COUNTRY
8.3. United Kingdom
9. COMPETITIVE INTELLIGENCE
9.1. Competitive Benchmarking and Analysis
9.2. Recent Investment and Deals
9.3. Strategies of Key Players
10. COMPANY PROFILES
10.1. Transplant Biomedicals
10.2. Veloxis Pharmaceuticals A/S
10.3. Bridge to Life Ltd.
10.4. Paragonix Technologies Inc.
10.5. Novartis AG
10.6. XVIVO Perfusion
10.7. F. Hoffmann-La Roche AG
LIST OF FIGURES
LIST OF TABLES
Veloxis Pharmaceuticals A/S
Bridge to Life Ltd.
Paragonix Technologies Inc.
F. Hoffmann-La Roche AG
All our studies come with 2 months of analyst support.
We are in compliance with the global privacy laws.